research alliance Jul 20, 2022 Repertoire Immune Medicines, MSK Partner to Study Immunogenic Profile in HPV-Positive Cancers Jul 6, 2022 Turnstone, Moffitt Cancer Center Get FDA Permission to Study TIL Therapy in Melanoma Patients Jun 24, 2022 MD Anderson, Turning Point Therapeutics Partner to Study Repotrectinib, Elzovantinib Jun 2, 2022 Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership Jun 1, 2022 Avera Health, Sema4 Launch Five-Year Precision Oncology Study May 24, 2022 Penn Medicine, CHOP to Support CAR T-Cell Research, Treatment in Costa Rica May 6, 2022 Drugmakers Come Together Hoping to Formalize MRD as Surrogate Endpoint in AML Trials Apr 28, 2022 Dante Labs, Abu Dhabi Stem Cells Center Ink Genetic Testing, mRNA Cancer Vaccine Development Deal Apr 26, 2022 International LAGENO-BC Consortium Spurring Breast Cancer Genetics Research Across Latin America Premium Apr 13, 2022 Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research Apr 12, 2022 In Sixth Year, Project GENIE Diversifying, Integrating Local Ancestry and Enhancing Clinical Data Premium Apr 8, 2022 Tempus Sets Sights on Pathology Market With New Informatics, Research Network Premium Feb 23, 2022 American Oncology Network, VieCure Ink Precision Oncology Partnership Jan 20, 2022 Transgene, PersonGen Biotherapeutics to Study Oncolytic Virus, Cell Therapy Combo in Solid Tumors Dec 2, 2021 Navigo Proteins, ITM Isotope Technologies Munich Partner on Targeted Radionuclide for Solid Tumors Sep 30, 2021 MD Anderson, Rare Cancer Research Foundation Team Up on Tissue Collection Effort Sep 24, 2021 Global Coalition for Adaptive Research Launches Adaptive Platform Trial for Ovarian Cancer Sep 1, 2021 New Research Consortium to Standardize Single-Cell Sequencing for Cancer Drug Resistance Studies Aug 12, 2021 Atlantic Cancer Consortium Gets $3.6M to Advance Precision Oncology Research in Canada Jul 28, 2021 MD Anderson, Blueprint Medicines Team Up to Bring CDK2 Inhibitor BLUE-222 to the Clinic Load More Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
